期刊
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
卷 14, 期 2, 页码 221-233出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737167.2014.894462
关键词
EQ-5D; smallest worthwhile effect; minimum relevant difference; review; minimum clinically important difference; Euro QoL
资金
- Chief Scientist Office of the Scottish Government Health and Social Care Directorates
- Chief Scientist Office [HERU1] Funding Source: researchfish
The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is the most common instrument to value health outcomes under the patient's perspective. Several studies have investigated whether observed changes are meaningful to patients, using a variety of approaches to estimate the minimum clinically important difference (MCID). This study provides an overview of the state of art of the estimation of the MCID for the three-level EQ-5D index based on the UK scoring algorithm, critically assessing the available evidence. The interest in estimation of MCID for the EQ-5D has been increasing in recent years. However, some additional standardization in the estimation procedures may be of value, in order to enhance the ability to make comparisons across measures and disease areas. Further methodological research might also contribute to reducing gaps between theory and practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据